Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells.

Miletic AV, Jellusova J, Cato MH, Lee CR, Baracho GV, Conway EM, Rickert RC.

J Immunol. 2016 Mar 1;196(5):2195-204. doi: 10.4049/jimmunol.1501690. Epub 2016 Jan 25.

2.

Transfection of microRNA Mimics Should Be Used with Caution.

Jin HY, Gonzalez-Martin A, Miletic AV, Lai M, Knight S, Sabouri-Ghomi M, Head SR, Macauley MS, Rickert RC, Xiao C.

Front Genet. 2015 Dec 2;6:340. doi: 10.3389/fgene.2015.00340. eCollection 2015.

3.

Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Jellusova J, Miletic AV, Cato MH, Lin WW, Hu Y, Bishop GA, Shlomchik MJ, Rickert RC.

Cell Rep. 2013 Nov 27;5(4):1022-35. doi: 10.1016/j.celrep.2013.10.022. Epub 2013 Nov 14.

4.

Subnuclear cyclin D3 compartments and the coordinated regulation of proliferation and immunoglobulin variable gene repression.

Powers SE, Mandal M, Matsuda S, Miletic AV, Cato MH, Tanaka A, Rickert RC, Koyasu S, Clark MR.

J Exp Med. 2012 Nov 19;209(12):2199-213. doi: 10.1084/jem.20120800. Epub 2012 Oct 29.

5.

Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Rickert RC, Jellusova J, Miletic AV.

Immunol Rev. 2011 Nov;244(1):115-33. doi: 10.1111/j.1600-065X.2011.01067.x. Review.

6.

Emergence of the PI3-kinase pathway as a central modulator of normal and aberrant B cell differentiation.

Baracho GV, Miletic AV, Omori SA, Cato MH, Rickert RC.

Curr Opin Immunol. 2011 Apr;23(2):178-83. doi: 10.1016/j.coi.2011.01.001. Epub 2011 Feb 1. Review.

7.

Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.

Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, Ravetch JV, Bolland S, Morse HC 3rd, Rickert RC.

J Exp Med. 2010 Oct 25;207(11):2407-20. doi: 10.1084/jem.20091962. Epub 2010 Oct 18.

8.

Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas.

Pedersen IM, Otero D, Kao E, Miletic AV, Hother C, Ralfkiaer E, Rickert RC, Gronbaek K, David M.

EMBO Mol Med. 2009 Aug;1(5):288-95. doi: 10.1002/emmm.200900028.

9.

Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells.

Wu S, Vossius S, Rahmouni S, Miletic AV, Vang T, Vazquez-Rodriguez J, Cerignoli F, Arimura Y, Williams S, Hayes T, Moutschen M, Vasile S, Pellecchia M, Mustelin T, Tautz L.

J Med Chem. 2009 Nov 12;52(21):6716-23. doi: 10.1021/jm901016k. Erratum in: J Med Chem. 2009 Dec 24;52(24):8058.

10.

Vav links the T cell antigen receptor to the actin cytoskeleton and T cell activation independently of intrinsic Guanine nucleotide exchange activity.

Miletic AV, Graham DB, Sakata-Sogawa K, Hiroshima M, Hamann MJ, Cemerski S, Kloeppel T, Billadeau DD, Kanagawa O, Tokunaga M, Swat W.

PLoS One. 2009 Aug 12;4(8):e6599. doi: 10.1371/journal.pone.0006599.

11.

Vav proteins are necessary for correct differentiation of mouse cecal and colonic enterocytes.

Liu JY, Seno H, Miletic AV, Mills JC, Swat W, Stappenbeck TS.

J Cell Sci. 2009 Feb 1;122(Pt 3):324-34. doi: 10.1242/jcs.033720. Epub 2009 Jan 12.

12.

Protein tyrosine phosphatases in autoimmunity.

Vang T, Miletic AV, Arimura Y, Tautz L, Rickert RC, Mustelin T.

Annu Rev Immunol. 2008;26:29-55. doi: 10.1146/annurev.immunol.26.021607.090418. Review.

PMID:
18303998
13.

Protein tyrosine phosphatase PTPN22 in human autoimmunity.

Vang T, Miletic AV, Bottini N, Mustelin T.

Autoimmunity. 2007 Sep;40(6):453-61. Review.

PMID:
17729039
14.

DLGH1 is a negative regulator of T-lymphocyte proliferation.

Stephenson LM, Sammut B, Graham DB, Chan-Wang J, Brim KL, Huett AS, Miletic AV, Kloeppel T, Landry A, Xavier R, Swat W.

Mol Cell Biol. 2007 Nov;27(21):7574-81. Epub 2007 Aug 27.

15.

Vav proteins control MyD88-dependent oxidative burst.

Miletic AV, Graham DB, Montgrain V, Fujikawa K, Kloeppel T, Brim K, Weaver B, Schreiber R, Xavier R, Swat W.

Blood. 2007 Apr 15;109(8):3360-8. Epub 2006 Dec 7.

16.

Vav proteins regulate the plasma cell program and secretory Ig production.

Stephenson LM, Miletic AV, Kloeppel T, Kusin S, Swat W.

J Immunol. 2006 Dec 15;177(12):8620-5.

17.

Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation.

Miletic AV, Sakata-Sogawa K, Hiroshima M, Hamann MJ, Gomez TS, Ota N, Kloeppel T, Kanagawa O, Tokunaga M, Billadeau DD, Swat W.

J Biol Chem. 2006 Dec 15;281(50):38257-65. Epub 2006 Oct 18.

18.

Vav1 promotes T cell cycle progression by linking TCR/CD28 costimulation to FOXO1 and p27kip1 expression.

Charvet C, Canonigo AJ, Bécart S, Maurer U, Miletic AV, Swat W, Deckert M, Altman A.

J Immunol. 2006 Oct 15;177(8):5024-31.

19.

Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics.

Graham DB, Cella M, Giurisato E, Fujikawa K, Miletic AV, Kloeppel T, Brim K, Takai T, Shaw AS, Colonna M, Swat W.

J Immunol. 2006 Aug 15;177(4):2349-55.

20.

Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.

Fujikawa K, Miletic AV, Alt FW, Faccio R, Brown T, Hoog J, Fredericks J, Nishi S, Mildiner S, Moores SL, Brugge J, Rosen FS, Swat W.

J Exp Med. 2003 Nov 17;198(10):1595-608.

21.

Cytoskeletal remodeling in lymphocyte activation.

Miletic AV, Swat M, Fujikawa K, Swat W.

Curr Opin Immunol. 2003 Jun;15(3):261-8. Review.

PMID:
12787750

Supplemental Content

Loading ...
Support Center